R&D Trends

BARDA awards Novan $7.8 million contract

Tuesday, August 27, 2013 11:30 AM

The U.S. Department of Health and Human Services has entered into a contract with Novan, a clinical-stage drug development company focused on topical delivery of nitric oxide, to advance the development of a nitric oxide-based therapy as a topical treatment for thermal burns. 

More... »

Curemark, VTT Molecular Sciences Institute collaborate

Tuesday, August 27, 2013 09:30 AM

Curemark, a drug R&D company focused on neurological disorders, has entered into a collaborative research agreement with the VTT Molecular Sciences Institute (MSI), an independent, nonprofit research institute in Berkeley, Calif.

More... »

CeMM, Haplogen make collection of human cell lines available

Monday, August 26, 2013 12:09 PM

Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public-private partnership. The partnership, through Haplogen, will distribute requested cell lines to the research community.

More... »

Mayo Clinic to open Phoenix stem cell lab

Friday, August 23, 2013 12:32 PM

Mayo Clinic in Arizona will open its own stem cell laboratory in summer 2014. The laboratory will be initially dedicated to storing and processing stem cells used for bone marrow transplants at Mayo Clinic Hospital and Phoenix Children's Hospital.

More... »

Shire, Santaris extend collaboration to discover and develop LNA-drugs

Friday, August 23, 2013 12:29 PM

Santaris Pharma, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, has announced that its long-term partner, Shire, has extended the existing partnership in the rare genetic disease space.  

More... »

Pediatric auditory brainstem implant clinical trial awarded NIH grant

Friday, August 23, 2013 11:48 AM

House Research Institute (HRI) and Los Angeles Children’s Hospital have announced final approval of grant funding by the NIH National Institute on Deafness and Communications Disorders (NIDCD) for a five-year, FDA-approved clinical trial of the auditory brainstem implant (ABI) in children.

More... »

Decision Resources suggests breast cancer market to reach $15B by 2022

Friday, August 23, 2013 11:39 AM

Decision Resources, a research and advisory firms for pharmaceutical and healthcare issues, finds that the uptake of premium-priced agents will fuel 5% annual growth in the breast cancer market, with sales reaching more than $15 billion in 2022 in the U.S., France, Germany, Italy, Spain, the U.K. and Japan.

More... »

Navidea awarded NIH SBIR grant

Wednesday, August 21, 2013 04:19 PM

Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute On Aging (NIA) of the NIH in connection with the company's phase III clinical program for its NAV4694 beta-amyloid imaging agent as an aid in the differential diagnosis of Alzheimer's disease.

More... »

Neurodegeneration Consortium receives $5 million from Huffington Foundation

Wednesday, August 21, 2013 11:02 AM

The Huffington Foundation has committed $5 million to the Neurodegeneration Consortium (NDC), a multi-institutional collaboration to study and treat Alzheimer’s and other neurodegenerative diseases.

More... »

Pancreatic Cancer Action Network study suggests national trial coordination needed

Wednesday, August 21, 2013 10:49 AM

The Pancreatic Cancer Action Network conducted a research study on the landscape of pancreatic cancer clinical trials in the U.S. in order to better understand how to accelerate clinical progress against pancreatic cancer and achieve the organization's goal to double the survival rate by 2020. The findings were published in the Journal of Clinical Oncology.

More... »